Media - published on 24 May 2019

Farma doet meer in arme landen

In NRC, Liza van Lonkhuyzen reports about the 10-year analysis , looking at how access to medicine has become a Board responsibility in almost all pharmaceutical companies measured.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |